Trial Profile
A Randomized, Single-Dose, Double-Blind, Active- and Placebo-Controlled Study of ADL5859 for the Treatment of Pain After Surgical Removal of Impacted Third Molars
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Dec 2023
Price :
$35
*
At a glance
- Drugs ADL 5859 (Primary) ; Ibuprofen
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors Adolor Corporation
- 21 Oct 2009 New trial record